John M. Kaczmar

John M. Kaczmar

Hematology | Oncology

86 Jonathan Lucas St
Charleston, SC 29425

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Mechanisms Underlying an Enhanced Navigation-Based Intervention to Improve Timely Adjuvant Therapy: A Secondary Analysis of the NDURE Randomized Clinical Trial.

Mechanisms Underlying an Enhanced Navigation-Based Intervention to Improve Timely Adjuvant Therapy: A Secondary Analysis of the NDURE Randomized Clinical Trial.

Journal: JAMA otolaryngology-- head & neck surgery

Published: July 23, 2026

Genome-wide variation in cell-free DNA end motif entropy predicts immunotherapy response in head and neck cancer.

Genome-wide variation in cell-free DNA end motif entropy predicts immunotherapy response in head and neck cancer.

Journal: The Journal of clinical investigation

Published: May 19, 2026

Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib Trial.

Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 08, 2026

Medication Samples and Smoking Cessation Among Adults: A Randomized Clinical Trial.

Medication Samples and Smoking Cessation Among Adults: A Randomized Clinical Trial.

Journal: JAMA network open

Published: May 08, 2026

Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective Study.

Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective Study.

Journal: medRxiv : the preprint server for health sciences

Published: April 10, 2026

Effects of NDURE on Timely Adjuvant Radiotherapy in HNSCC: Subgroup Analysis of an RCT.

Effects of NDURE on Timely Adjuvant Radiotherapy in HNSCC: Subgroup Analysis of an RCT.

Journal: The Laryngoscope

Published: April 02, 2026

Lenvatinib plus pembrolizumab versus standard of care in recurrent/metastatic head and neck squamous cell carcinoma: Randomized, phase 2 LEAP-009 trial.

Lenvatinib plus pembrolizumab versus standard of care in recurrent/metastatic head and neck squamous cell carcinoma: Randomized, phase 2 LEAP-009 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 10, 2026

Fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab: Tumor-specific expansion cohorts in advanced malignancies.

Fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab: Tumor-specific expansion cohorts in advanced malignancies.

Journal: Cancer

Published: November 04, 2025

Genome-wide variation in cell-free DNA end-motif entropy predicts immunotherapy response in head and neck cancer.

Genome-wide variation in cell-free DNA end-motif entropy predicts immunotherapy response in head and neck cancer.

Journal: The Journal of clinical investigation

Published: October 20, 2025

Rationale, design, and protocol for a sequential, multiple assignment, randomized trial of adaptive treatment for smoking cessation: The ADAPT trial.

Rationale, design, and protocol for a sequential, multiple assignment, randomized trial of adaptive treatment for smoking cessation: The ADAPT trial.

Journal: Contemporary clinical trials

Published: June 30, 2025

Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma.

Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 31, 2025

Preventing Cisplatin-Induced Hearing Loss in Adults: A Systematic Review and Meta-Analysis.

Preventing Cisplatin-Induced Hearing Loss in Adults: A Systematic Review and Meta-Analysis.

Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology

Published: February 18, 2025

Showing 1-12 of 41

Last Updated: 09/26/2026